Epigenetic therapies, still in the midway between facts and fiction
Reumatol Clin. 2017 Nov-Dec;13(6):311-312.
doi: 10.1016/j.reuma.2017.05.001.
Epub 2017 May 30.
[Article in
English,
Spanish]
Affiliation
- 1 Division of Rheumatology, Jimenez Diaz Foundation University Hospital and Health Research Institute, Autonoma University, Madrid, Spain. Electronic address: [email protected].
No abstract available
MeSH terms
-
DNA Methylation / drug effects
-
DNA-Cytosine Methylases / antagonists & inhibitors
-
Epigenesis, Genetic* / drug effects
-
Genetic Therapy* / trends
-
Histone Deacetylase Inhibitors / therapeutic use
-
Humans
-
Inflammation / prevention & control
-
Inflammation / therapy
-
Molecular Targeted Therapy
-
Neoplasms / drug therapy
-
Neoplasms / therapy
-
Rheumatic Diseases / therapy
-
Therapies, Investigational*
Substances
-
Histone Deacetylase Inhibitors
-
DNA-Cytosine Methylases